江苏阜宁县50岁以上2型糖尿病患者盲与中重度视力损伤流行病学调查
以日常生活视力计算,盲和中重度视力损伤患病率分别为5.29%和18.54%;以最佳矫正视力计算分别为3.67%和9.80%。首要致病原因为白内障,其次为糖尿病视网膜病变。
要点
- 50岁以上2型糖尿病患者盲和中重度视力损伤患病率较高。
- 日常生活视力下盲患病率5.29%,中重度视力损伤18.54%。
- 最佳矫正视力下盲患病率3.67%,中重度视力损伤9.80%。
核心结论
- 阜宁县50岁以上2型糖尿病患者盲和中重度视力损伤患病率较高,应重视该人群的防盲工作。
研究设计与样本
- 横断面研究,采用整群随机抽样抽取84个调查地点。
- 调查对象为阜宁县疾病预防控制中心慢病信息中心登记的50岁以上2型糖尿病患者。
主要发现
- 以日常生活视力计算,盲和中重度视力损伤患病率分别为5.29%(95%CI:4.29%~6.30%)和18.54%(95%CI:16.80%~20.29%)。
- 以最佳矫正视力计算,盲和中重度视力损伤患病率分别为3.67%(95%CI:2.82%~4.51%)和9.80%(95%CI:8.46%~11.13%)。
- 日常生活视力下盲的患病率与年龄、婚姻状况、文化程度、糖尿病患病时间、糖尿病肾病、收缩压及晶状体核混浊度相关。
- 日常生活视力下中重度视力损伤与年龄、性别、文化程度、糖尿病治疗方法、锻炼及糖化血红蛋白相关。
- 最佳矫正视力下盲的患病率与年龄、婚姻状况、文化程度、糖尿病患病时间、糖尿病肾病、锻炼及收缩压相关;中重度视力损伤与年龄、文化程度、糖尿病治疗方法及晶状体核混浊度相关。
关键数值与推荐
- 盲和中重度视力损伤的患病率分别按日常生活视力和最佳矫正视力计算。
- 日常生活视力下盲和中重度视力损伤分别为101例和354例。
- 最佳矫正视力下盲和中重度视力损伤分别为70例和187例。
临床怎么用
- 对50岁以上2型糖尿病患者应关注白内障和糖尿病视网膜病变的筛查与防治。
- 控制收缩压、糖化血红蛋白及糖尿病肾病等可能相关因素或有助于降低视力损伤风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the prevalence, causes and risk factors of moderate or severe visual impairment and blindness in people with type 2 diabetes over 50 years old in Funing County, Yancheng. Methods: This is a cross-sectional study. Using cluster random sampling, 84 survey sites were selected, and eye examination was performed on people with type 2 diabetes over 50 years old who were registered with the chronic disease information center of Funing County Center for Disease Control and Prevention in Yancheng, Jiangsu. The prevalence of moderate or severe visual impairment and blindness were calculated by different ages and genders. The causes of blindness and visual impairment were determined, and their influencing factors were analyzed by univariate and multivarite logistic regression. Results: A total of 2 067 people were investigated in this study, and 1 909 people were included. The response rate was 92.4%. Based on PVA, the prevalence of blindness and moderate to severe visual impairment was 5.29% (95%CI: 4.29%-6.30%) and 18.54% (95%CI: 16.80%-20.29%). The prevalence of blindness was related to age, marital status, education, duration of diabetes, history of diabetic nephropathy, systolic blood pressure and nuclear opacity. The prevalence of moderate or severe visual impairment was related to age, gender, educational level, diabetes treatment, exercise, and glycated hemoglobin. The prevalence of blindness and moderate to severe visual impairment was 3.67% (95%CI: 2.82%-4.51%) and 9.80% (95%CI: 8.46%-11.13%) based on BCVA. The prevalence of blindness was related to age, marital status, education, duration of diabetes, history of diabetic nephropathy, exercise and systolic blood pressure, while the prevalence of moderate or severe visual impairment was related to age, educational level, diabetes treatment and nuclear opacity. The primary cause of blindness and visual impairment is cataract, followed by diabetic retinopathy. Conclusions: The prevalence of moderate or severe visual impairment and blindness in people with type 2 diabetes in Funing County is relatively high. Attention should be paid to the prevention of blindness in this population. (Chin J Ophthalmol, 2020, 56: 593-599). 目的: 了解江苏省盐城市阜宁县50岁以上2型糖尿病患者盲和中重度视力损伤的患病率、致病原因和危险因素。 方法: 横断面研究。采用整群随机抽样抽取84个调查地点,对江苏省盐城市阜宁县疾病预防控制中心慢病信息中心登记的50岁以上2型糖尿病患者进行眼部检查。分别计算不同年龄、性别盲和中重度视力损伤的患病率,确定盲和视力损伤的原因,并采用单因素和多因素Logistic回归分析其影响因素。 结果: 共调查2 067人,纳入统计分析1 909人,受检率为92.4%。以日常生活视力计算,盲和中重度视力损伤分别为101和354例,患病率分别为5.29%[95%可信区间(CI):4.29%~6.30%]和18.54%(95%CI:16.80%~20.29%),盲的患病率与年龄、婚姻状况、文化程度、糖尿病患病时间、是否患糖尿病肾病、收缩压高低及晶状体核混浊度相关,中重度视力损伤与年龄、性别、文化程度、糖尿病治疗方法、是否锻炼及糖化血红蛋白相关;以最佳矫正视力计算,盲和中重度视力损伤分别为70和187例,患病率分别为3.67%(95%CI:2.82%~4.51%)和9.80%(95%CI:8.46%~11.13%),盲的患病率与年龄、婚姻状况、文化程度、糖尿病患病时间、是否患糖尿病肾病、是否锻炼及收缩压高低相关,中重度视力损伤与年龄、文化程度、糖尿病治疗方法及晶状体核混浊度相关。导致盲和视力损伤的首要原因均为白内障,其次是糖尿病视网膜病变。 结论: 江苏省盐城市阜宁县2型糖尿病患者中盲和中重度视力损伤的患病率较高,其主要原因为白内障和糖尿病视网膜病变。(中华眼科杂志,2020,56:593-599).
引用
- Shen YQ, Yang M, Liu BH, et al. [Jiangsu Diabetic Eye Disease Study:epidemiological survey of blindness and moderate or severe visual impairment in people with type 2 diabetes over 50 years old in Funing County]. Zhonghua Yan Ke Za Zhi. 2020. PMID: 32847334. doi:10.3760/cma.j.cn112142-20200226-00119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。